SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-054482
Filing Date
2020-04-30
Accepted
2020-04-30 16:35:06
Documents
5
Effectiveness Date
2020-04-30

Document Format Files

Seq Description Document Type Size
1 S-8 tm2017930-1_s8.htm S-8 63078
2 EXHIBIT 5.1 tm2017930d1_ex5-1.htm EX-5.1 11810
3 EXHIBIT 23.1 tm2017930d1_ex23-1.htm EX-23.1 1887
4 GRAPHIC tm2017930d1_ex5-1img001.jpg GRAPHIC 9481
5 GRAPHIC tm2017930d1_ex5-1img002.jpg GRAPHIC 2522
  Complete submission text file 0001104659-20-054482.txt   94657
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237933 | Film No.: 20836197
SIC: 2834 Pharmaceutical Preparations